登录

Universal Medical Snares ¥600M in Series B Financing

作者: Mailman 2020-02-10 17:37
全景医学影像
http://www.uvclinic.cn
企业数据由 动脉橙 提供支持
医疗服务提供商 | 股权融资 | 运营中
中国-上海
2020-12-31
曜金资本
查看

According to lieyunwang.com, Shanghai-based Universal Medical Imaging Diagnostic ("Universal Medical") has secured over 600 million yuan (US $86 million) in its Series B round, led by CEC Capital-owned industrial fund, Cathay Capital, and V Star Capital, an investment management spinoff from GGV Capital, with participation from other investors include state-owned Tianjin Teda Group and JuneYao-backed GT Capital while existing investor Tianjin Hidea Investment Management Co., Ltd also infused money.


Proceeds of this financing will be used to build its operations network and also to enhance the network of its operations and its supply chain management.


Founded in June 2015 with the registered capital of 201.27792 million yuan, Universal Medical has more than 60 talents with senior titles such as doctor, professor and chief physician. In addition, it cooperates with Siemens and GE in the field of image diagnosis, training imaging doctors for hospitals around the world.


Universal Medical is the pioneer of the independent third-party imaging center in China. The company focuses on imaging diagnosis of difficult diseases, providing accurate imaging diagnosis services, health examination services, multidisciplinary joint consultation and other individual medical services for patients.


Universal Medical has "Multi-Mode" imaging screening equipment -- PET/MR, which can screen the whole body for a variety of benign and malignant tumors, cardiovascular and cerebrovascular diseases and neurological diseases. It is also equipped with PET/CT, flash dual-source spiral CT, MR (magnetic resonance) and so on.


>>>>

About Cathay Capital


Cathay Capital is a leading international private equity firm active in cross-border investment. It supports the international expansion of middle-market companies in North America, China and Europe. Its team of 60 professionals based in New York, Shanghai, Beijing, Paris, Munich, and Silicon Valley leverages Cathay's business model and platform to create value for companies. With more than US$1.5 billion in assets under management, Cathay Capital has completed buyouts and growth capital investments in 59 platform companies across three continents.


>>>>

About V Star Capital


Founded in 2016, V Star Capital manages 5 RMB funds and 1 USD fund, mainly focusing on health care, smart technology plus ("new drivers plus"), consumption upgrade, TMT, etc., with the investment stage covers early stage and growth stage.

相关赛道 医学影像
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

辰德资本合伙人谈庆:狙击医疗器械创新,技术变革带动市场新机遇【投资人说】

Maimo Zhenkong Snags ¥10M in Series A Funding Round

Shenzhi Technology Snags ¥10M in Series A, Focusing on Artificial Intelligence in Ultrasound

Fussen Snares $14M in Series C Round, Focusing on Digital Dental Ecology Platform

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

11分钟完成审批,国家卫健委要求大力发展,互联网诊疗服务在如何支撑疫情防控需求?

2020-02-10
下一篇

"Menxlab Manshi" Completes ¥10M Angel Round of Financing

2020-02-10